Neurologic outcomes of pediatric epileptic patients with pentobarbital coma

S J Kim1, D Y Lee, J S Kim

  • 1Department of Pediatrics, Institute for Medical Science, Chonbuk National University, Medical School, Chonju, Chonbuk, South Korea.

Pediatric Neurology
|October 6, 2001
PubMed

Insights

Refractory status epilepticus treatment with pentobarbital coma showed that patients responding to pentobarbital had no deaths. Failure to control seizures with pentobarbital coma indicated a poor prognosis.

Area of Science:

  • Neurology
  • Pediatric Neurology
  • Critical Care Medicine

Background:

  • Status epilepticus is a critical neurological emergency.
  • Refractory status epilepticus (RSE) necessitates advanced treatment strategies.
  • High-dose pentobarbital is a common intervention for RSE in children.

Purpose of the Study:

  • To assess the link between pentobarbital coma response and neurological outcomes in pediatric RSE.
  • To identify prognostic factors for patients with RSE treated with pentobarbital.

Main Methods:

  • Retrospective review of 23 pediatric patients treated with pentobarbital coma for at least 48 hours.
  • Data collection included demographics, treatment response, and neurological outcomes.
  • Patients were categorized into responders, non-responders, and relapsers.

Main Results:

  • Twelve patients responded to pentobarbital, six were unresponsive, and five relapsed.
  • The combined mortality rate for non-responders and relapsers was 90.9%, versus 0% for responders (P < 0.001).
  • Toddlers had a better survival rate than neonates or older children; RSE treatment failure predicted poor prognosis.

Conclusions:

  • Pentobarbital coma response is a significant predictor of neurological outcomes in RSE.
  • Failure to achieve seizure control with pentobarbital coma is associated with high mortality.
  • Neonatal RSE requires cautious pentobarbital dosing due to potential complications.

Related Concept Videos

General Anesthesia: Overview01:24

General Anesthesia: Overview

Anesthesia is a medical procedure that uses drugs for CNS suppression to enable painless surgeries and procedures. The selection of anesthetics is influenced by their pharmacokinetic properties, side effects, and patient characteristics. Various types of anesthesia include general, local, regional, spinal, and inhalational.
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...